In the last trading session, 8.71 million shares of the Novavax, Inc (NASDAQ:NVAX) were traded, and its beta was 2.76. Most recently the company’s share price was $6.49, and it changed around -$0.54 or -7.68% from the last close, which brings the market valuation of the company to $1.05B. NVAX currently trades at a discount to its 52-week high of $17.81, offering almost -174.42% off that amount. The share price’s 52-week low was $5.01, which indicates that the current value has risen by an impressive 22.8% since then.
Novavax, Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.71. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended NVAX as a Hold, whereas 3 deemed it a Buy, and 1 rated it as Underweight.
Novavax, Inc (NASDAQ:NVAX) trade information
Instantly NVAX has showed a red trend with a performance of -7.68% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 7.51 on recent trading dayincreased the stock’s daily price by 13.58%. The company’s shares are currently down -19.28% year-to-date, but still down -9.86% over the last five days. On the other hand, Novavax, Inc (NASDAQ:NVAX) is -3.57% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $22, which translates to bulls needing to increase their stock price by 70.5% from its current value. Analyst projections state that NVAX is forecast to be at a low of $14 and a high of $174.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 25.88%.
NVAX Dividends
Novavax, Inc’s next quarterly earnings report is expected to be released on 2025-May-07.
Novavax, Inc (NASDAQ:NVAX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 8.77% of Novavax, Inc shares, and 57.29% of them are in the hands of institutional investors. The stock currently has a share float of 62.80%. Novavax, Inc stock is held by 323.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 9.4861% of the shares, which is about 14.08 million shares worth $178.19 million.
BLACKROCK INC., with 7.984% or 11.85 million shares worth $149.98 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
